EGenesis

Cambridge, MA, USA

3 employees

Biopharma

Series D · $481M

About EGenesis

EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It offers a gene editing and genome engineering platform to develop human-compatible organs, tissues, and cells, aiming to provide an alternative solution to the global organ shortage.

Open positions (4)

Company details

Team Size3

LocationCambridge, MA, USA

IndustryBiopharma

Funding

Total raised

$481M

Last stage

Series D

Investors

Lux Capital

ARCH Venture Partners

Khosla Ventures

Farallon Capital Management

LLeaps by Bayer

Founders

Geoff MacKay

Listed as a co-founder of eGenesis on Crunchbase.

George Church

Renowned Harvard Medical School geneticist; co-founded eGenesis in 2015 with former PhD student Luhan Yang based on breakthrough CRISPR genome engineering research at the Church Lab.

Luhan Yang

PhD in human biology and translational medicine from Harvard Medical School; co-founded eGenesis with George Church in 2015; pioneered CRISPR-based inactivation of porcine endogenous retroviruses (PERVs) to advance xenotransplantation.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.